MG
CL icon

Michael Gelband’s Colgate-Palmolive CL Stock Holding History

Michael Gelband’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
+13,094
New +$1.15M 0.01% 1015
2025
Q2 		– Sell
-81,389
Closed -$7.63M – 1524
2025
Q1 		$7.63M Buy
+81,389
New +$7.29M 0.08% 282
2024
Q1 		– Sell
-24,033
Closed -$1.92M – 1541
2023
Q4 		$1.92M Sell
24,033
-151,075
-86% -$11.4M 0.01% 591
2023
Q3 		$12.5M Sell
175,108
-258,771
-60% -$19.3M 0.12% 181
2023
Q2 		$33.4M Sell
433,879
-446,488
-51% -$34.6M 0.27% 63
2023
Q1 		$66.2M Buy
880,367
+711,412
+421% +$52.9M 0.55% 20
2022
Q4 		$13.3M Sell
168,955
-66,835
-28% -$5.01M 0.19% 123
2022
Q3 		$16.6M Buy
235,790
+8,195
+4% +$643K 0.22% 95
2022
Q2 		$18.2M Buy
227,595
+72,737
+47% +$5.69M 0.22% 85
2022
Q1 		$11.7M Buy
+154,858
New +$12.3M 0.15% 151
2021
Q4 		– Sell
-271,964
Closed -$20.6M – 2204
2021
Q3 		$20.6M Buy
271,964
+75,664
+39% +$6.01M 0.28% 58
2021
Q2 		$16M Buy
196,300
+73,027
+59% +$5.97M 0.18% 72
2021
Q1 		$9.72M Buy
123,273
+80,051
+185% +$6.27M 0.14% 130
2020
Q4 		$3.7M Buy
43,222
+25,443
+143% +$2.1M 0.04% 335
2020
Q3 		$1.37M Sell
17,779
-81,372
-82% -$6.2M 0.03% 548
2020
Q2 		$7.26M Sell
99,151
-70,465
-42% -$5.01M 0.19% 96
2020
Q1 		$11.3M Sell
169,616
-236,558
-58% -$16.7M 0.62% 20
2019
Q4 		$28M Buy
406,174
+235,505
+138% +$16.1M 0.52% 14
2019
Q3 		$12.5M Sell
170,669
-134,445
-44% -$9.75M 0.44% 48
2019
Q2 		$21.9M Buy
+305,114
New +$21.7M 0.87% 15
2019
Q1 		– Sell
-9,165
Closed -$546K – 680
2018
Q4 		$546K Buy
+9,165
New +$573K 0.04% 137

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Michael Gelband's CL Position: Q2 2026 in Review

Michael Gelband opened a new position in Colgate-Palmolive (CL) in Q2 2026: 13,094 shares worth $1.2M. The stake represents 0.01% of the portfolio and ranks #1015 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CL as recently as Q1 2025.

Michael Gelband first reported a position in CL in Q4 2018 and has held it in 21 quarters since. The position peaked at $66.2M in Q1 2023. 2,007 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Michael Gelband held 13,094 shares of Colgate-Palmolive worth $1.2M as of Q2 2026.
  • Colgate-Palmolive was a new Michael Gelband position in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1015 holding.
  • Michael Gelband first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 21 quarters since.
  • Michael Gelband's Colgate-Palmolive position peaked at $66.2M in Q1 2023.
  • 2,007 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.